临床利用头孢哌酮舒巴坦钠腹腔注药治疗严重肝病腹水感染的效果  

Treatment of Severe Liver Disease with Ascites Infection by Intraperitoneal Injection of Cefoperazone and Sulbactam

作　　者：彭艳丽 PENG Yanli(The District People’s Hospital of Yunyang in Shiyan,Shiyan 442500,China)

机构地区：[1]十堰市郧阳区人民医院,湖北十堰442500

出　　处：《中外医学研究》2018年第9期19-20,共2页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的:探析肝硬化并发自发性腹膜炎(SBP)采取头孢哌酮舒巴坦钠腹腔注药治疗的临床效果。方法:选取2014年7月-2017年7月笔者所在医院接收的肝硬化SBP患者66例为参研样本,随机均分为两组,参照组采用头孢噻肟钠治疗,干预组采用头孢哌酮舒巴坦钠治疗。对比两组治疗的效果及肝功能改善的情况。结果:干预组总有效率93.9%,显著高于参照组的66.7%,总胆红素(TBIL)与丙氨酸转氨酶(ALT)均优于参照组,差异均有统计学意义(字2=7.759 1,t=6.516 6、19.715 1,P<0.05)。结论:头孢哌酮舒巴坦钠腹腔注药用于肝硬化SBP治疗中的效果确切。Objective:Clinical effect of intraperitoneal injection of Cefoperazone Sulbactam Sodium in patients with cirrhosis complicated with spontaneous peritonitis(SBP).Method:From July 2014 to July 2017,66 patients with SBP of cirrhosis received in our hospital were randomly divided into two groups,the control group was treated with Cefotaxime Sodium,the intervention group was treated with Cefoperazone Sulbactam Sodium.Result:The total effective rate of 93.9%in the intervention group was significantly higher than 66.7%in the reference group,the total bilrubin(TBIL)and alanine aminotransferase(ALT)were better than those of reference group,the differences were statistically significant(X2=7.759 1,t=6.516 6,19.715 1,P<0.05).Conclusion:Cefoperazone Sulbactam Sodium intraperitoneal injection in the treatment of cirrhosis with SBP is effective.

关 键 词：自发性腹膜炎 头孢哌酮舒巴坦钠 肝功能 腹腔注药 

分 类 号：R575[医药卫生—消化系统]